Standard Biotools (LAB) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.92% |
| Dec 31, 2025 | 22.61% |
| Sep 30, 2025 | -39.49% |
| Jun 30, 2025 | -20.79% |
| Mar 31, 2025 | -10.25% |
| Dec 31, 2024 | 25.34% |
| Sep 30, 2024 | -15.89% |
| Jun 30, 2024 | -27.16% |
| Mar 31, 2024 | -4.78% |
| Dec 31, 2023 | -6.00% |
| Sep 30, 2023 | -7.32% |
| Jun 30, 2023 | -0.97% |
| Mar 31, 2023 | -4.92% |
| Dec 31, 2022 | -14.79% |
| Sep 30, 2022 | -13.04% |
| Jun 30, 2022 | -30.28% |
| Mar 31, 2022 | -34.70% |
| Sep 30, 2021 | 6.90% |
| Jun 30, 2021 | 1.64% |
| Mar 31, 2021 | 1.09% |
| Dec 31, 2020 | -6.96% |
| Sep 30, 2020 | 8.33% |
| Jun 30, 2020 | 3.10% |
| Mar 31, 2020 | -0.06% |
| Dec 31, 2019 | -3.00% |
| Sep 30, 2019 | 1.35% |
| Jun 30, 2019 | -1.63% |
| Mar 31, 2019 | -10.56% |
| Dec 31, 2018 | -26.05% |
| Sep 30, 2018 | -28.04% |
| Jun 30, 2018 | -32.04% |
| Mar 31, 2018 | -30.12% |
| Dec 31, 2017 | -23.76% |
| Sep 30, 2017 | -30.88% |
| Jun 30, 2017 | -29.89% |
| Mar 31, 2017 | -20.79% |
| Dec 31, 2016 | -38.62% |
| Sep 30, 2016 | -34.54% |
| Jun 30, 2016 | -20.97% |
| Mar 31, 2016 | -22.06% |
| Dec 31, 2015 | -33.14% |
| Sep 30, 2015 | -22.36% |
| Jun 30, 2015 | -25.89% |